Phase III trials now include 42% more procedures and 37% more endpoints compared to a decade ago A significant portion of collected data is not directly tied to primary endpoints, adding operational burden without improving outcomes According to Tufts Center for the Study of Drug Development, complexity continues to increase across all phases, affecting timelines, costs, and site workload For sponsors, this translates into longer start-up timelines, more amendments, and increased execution risk
This lack of motility, the muscle movements within your GI tract that move food forward through the digestive process, causes nausea, vomiting, and premature fullness
Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al
Relaxation is not a platitude Tense muscles make injections hurt more